This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Sand, Peter
| Item Type | Name |
|
Concept
|
Mandelic Acids
|
|
Academic Article
|
Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group.
|
|
Academic Article
|
Treatment of detrusor instability with oxybutynin rectal suppositories.
|
|
Academic Article
|
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
|
|
Academic Article
|
Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study.
|
|
Academic Article
|
Elevating our therapeutic expectations in overactive bladder.
|
|
Academic Article
|
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.
|
|
Academic Article
|
Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review.
|
|
Academic Article
|
Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial.
|
|
Academic Article
|
The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial.
|
|
Academic Article
|
A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women.
|
|
Academic Article
|
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
|
|
Academic Article
|
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
|
|
Academic Article
|
Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study.
|
|
Academic Article
|
Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference.
|
|
Academic Article
|
The evolution of transdermal therapy for overactive bladder.
|
|
Academic Article
|
Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome.
|
|
Academic Article
|
Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study.
|
|
Academic Article
|
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.
|
|
Academic Article
|
Oxybutynin: past, present, and future.
|
|
Academic Article
|
Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study.
|